Read on Twitter
At this stage will literally consider *anything* to reopen venues. But there are some massive logistical, practical and policy hurdles to overcome in using rapid-testing to reopen theatres.
For a start, business is built on advance sales; who will buy a ticket up front if there’s a risk they won’t be admitted on the day? And do venues/producers refund if someone tests positive?
How do large capacity venues evidence negative tests from each audience member?
Or is the idea that tests are carried out immediately before entry. In which case, who will queue in the rain for half an hour waiting for a result?
Or is the idea that tests are carried out immediately before entry. In which case, who will queue in the rain for half an hour waiting for a result?
What about access to sufficient tests? Literally need thousands a night in some cases.
And who covers the cost? Does this add to the cost of a night at the theatre for the customer, or does the venue (or government) underwrite?
And who covers the cost? Does this add to the cost of a night at the theatre for the customer, or does the venue (or government) underwrite?
There may be technological solutions of course. ie tests carried out in advance by the customer. Logged through NHS site and mobile phone confirmation used as evidence on arrival. But still presents barriers for some customers; and back up plans would be required.
None of which is to say it’s impossible - just that there’s a need to properly consider the implications. And for that to happen DCMS needs to engage in meaningful consultation across the sector.
